Search for a condition, service or location

Translate this page



Help in a crisis


If there is an immediate danger to life, please dial 999 or go to your nearest Accident and Emergency Department.

I am in Gloucestershire

If you or someone you know needs help in a mental health crisis, call our crisis teams.

Call 0800 169 0398.

And choose one of the following options depending on your location:

  • Option 1 for Stroud and Cotswolds
  • Option 2 for Gloucester and Forest
  • Option 3 for Cheltenham, Tewkesbury and North Cotswolds

Please note: telephone calls may be recorded. If you do not want that to happen, please tell the person who answers your call and they will phone you back on a ‘non-recordable’ telephone.

The number is available 24 hours a day, 7 days a week. Occasionally, callers may be asked to leave their name and number on an answerphone. In these circumstances, staff will return the call within one hour.

I am in Herefordshire

If you are in Herefordshire, please call: 01432 364046

The number is available 24 hours a day, 7 days a week.

If you need help but are not in crisis, please contact your GP if in opening hours, or 111. If you don’t have a GP use the NHS service search to locate the nearest one to you. If your query is not urgent, you can find our contact details here.

Are you feeling vulnerable? Do you need to talk to somebody now?


Call free on 116 123
If you are experiencing feelings of distress or despair, including those which could lead to suicide, you can call the Samaritans.

Stay Alive App

A pocket suicide prevention resource for the UK, packed full of useful information and tools to help you stay safe in crisis. You can use it if you are having thoughts of suicide or if you are concerned about someone else who may be considering suicide. The app can be accessed through the Apple Store, Google Play and downloaded as a pdf.


Call free on 0800 11 11
If you are a child or a young person you may want to speak to Childline.


Call 0808 816 0606
A safe, supportive, non-judgmental and informative service for people who self harm, their friends, families and carers.


Our research team participates in national and local studies, aimed at increasing our understanding of mental health conditions, improving the services we provide and helping to develop new treatments.

Clinical research within health services has become more important than ever. Government policy requires NHS Trusts to ensure patients are informed about NHS research, are supported to make choices about taking part in it and ultimately receive the best possible care.

²gether has been involved in research for the last 15 years. Our research department has grown from one funded research nurse in 2009 to a team which now includes research nurses, research practitioners and administration support.

We have a dedicated research centre based in Cheltenham where the team works alongside other clinical teams within the trust.

We encourage participants to sign up to our research studies across all of our service areas throughout Herefordshire and Gloucestershire. You can find details of studies currently recruiting participants below.

Our vision is to be a world-class centre of practice-based research and development to help make life better.

All research follows strict guidelines and governance procedures laid down by the National Institute for Health Research (NIHR).

Studies Currently Recruiting Participants

If you are interested in taking part in any of our studies, or would like to find out more, contact the research team.

Telephone: 01242 634490
Email: 2gnft.research@nhs.net

AD Genetics

The purpose of the Alzheimer’s Disease Genetics Study is to help identify the genes that may be responsible for causing Alzheimer’s Disease.

Who can get involved?

This study has two groups, early onset and late onset Alzheimer’s disease. We are inviting people who first experienced symptoms of Alzheimer’s disease before the age of 65 (early onset) and between the ages of 66 and 70 (late onset) to help with this research.

What do participants need to do?

  • The patient and a family member, friend or carer will each complete a questionnaire during a one off visit which can take up to two and a half hours.
  • The patient is required to give a blood sample which will be collected by a member of the research team during the assessment.

Exploring the cause and prevalence of memory problems in people with mental health, neuro-developmental and neuro-degenerative disorders.

Who can get involved?

  • Anyone, whether or not they have a diagnosis of a mental health condition or dementia.
  • Age over 16 years.
  • Fluent in English language.

What do participants need to do?

The participants will be asked to complete a questionnaire which will take approximately 15-20 minutes.


PPiP-2 is the follow up study for PPiP. The first phase (PPiP) was looking at the presence of antibodies in patients with first episode psychosis. This pilot study provided the first systematic evidence that some cases of schizophrenia may have an immune mediated disorder.  PPiP-2 aims to look at its prevalence in patients with a more general diagnosis of psychosis.

Who can get involved?

Participants must be aged 18-70 with acute psychosis symptoms lasting for at least the past two weeks but no longer than two years, and not a primary drug induced psychosis.

What do participants need to do?

We will arrange a suitable time to meet with you and complete the following:

  • Sign a consent form
  • Provide a blood sample
  • Ask a few short questions, lasting approx. 15 minutes.
Bipolar Disorder Research Network (BDRN): Molecular Genetics

A genetic study looking into how genes and external factors (like stressful life events) interact with each other to make people more likely to develop bipolar disorder than others.

Who can get involved?

Participants must:

  • Have had a Bipolar diagnosis with at least one episode of mania/hypomania at any time in the past (including: bipolar I disorder, bipolar II disorder, bipolar disorder not otherwise specified, post-partum psychosis or schizoaffective disorder)
  • Be over 18
  • Speak and understand English fluently
  • Be able to provide written consent

What do participants need to do?

  • An interview in your own home or over the telephone to ask about your experiences and the kind of symptoms you’ve had in the past.
  • Complete some questionnaires.
  • Potentially give a small blood sample: this is for the genetic aspect of the investigation.

Study examining what leads to the development of mental health problems, from genetics and biology to psychological and environmental factors.

Who can get involved?

Participants with a diagnosis of:

  • Bipolar affective disorder (type 1/type2/NOS)
  • Schizophrenia
  • Schizoaffective (bipolar/depressed types)
  • Psychosis (including post-natal psychosis)
  • PTSD
  • A learning disability

What do participants need to do?

  • A blood test
  • A short questionnaire

A randomised controlled trial of an online intervention for carers who are supporting someone affected by psychosis.

Who can get involved?

  • You need to be a carer of a person affected by psychosis
  • You need to have at least weekly contact with the person you care for although these contacts do not have to be face to face
  • You need to be living in England
  • You need daily access to the internet
  • You must be over 18.

What do participants need to do?

  • The study consists of a 20 week intervention where you will need to spend about one hour per week using an online platform. This will be alongside any other care.
  • People who are randomised into control and usual care will still receive the intervention after 20 weeks.
Adult Autism Cohort

Very little research has been undertaken into the life experiences of adults and older people on the autism spectrum. The aim of this study is to collect information from adults on the autism spectrum and their relatives, and update the information from time to time to see how people’s lives change.

Who can get involved?

  • adults on the autism spectrum of all ages and abilities
  • relatives are able to join and give information about themselves and their own lives
  • some relatives or carers can respond for people with an autism spectrum condition who cannot take part themselves

What do participants need to do?

  • Complete questionnaires at various time points either online or by post.
Graduate 2

A trial to test the effect of an investigational treatment (GANTENERUMAB, a monoclonal antibody) for people who may be in the early stages of Alzheimer’s disease.

Who can get involved?

  • Participants must be aged 50-90 with mild Alzheimer’s disease or MCI.
  • Participants must have a friend or relative who knows them well and can act as a study partner. This will include attending clinic visits when necessary and answering questions on symptoms and how the participant is coping day-to-day.

What do participants need to do?

  • Attend clinic every 4 weeks
  • Have a sub-cut (SC) injection every 4 weeks of either the active drug or a placebo (a product that looks exactly the same but does not contain the study drug)
  • Have a medical exam including an Electrocardiogram (ECG) on a regular basis
  • Provide regular blood samples
  • Complete some memory questionnaires
  • Have Magnetic Resonance Imaging (MRI) scans throughout the study.

Useful Links:

Join Dementia Research (JDR)


Alzheimer’s society


Carer’s Gloucestershire


Who our partners are

National Institute of Health Research (NIHR)

  • Improving the health and wealth of the nation through research
  • Funded by the Department of Health to improve the health and wealth of the nation through research
  • Ensure the NHS is able to support the research of other funders to encourage broader investment in, and economic growth from, health research
  • Work with charities and the life sciences industry to help patients gain earlier access to breakthrough treatments
  • Train and develop researchers to keep the nation at the forefront of international research

Cobalt Health

  • A diagnostic imaging Centre
  • Provide MRI and PET scans for our clinical trials

Locations for this service